Boston Scientific (BSX) Granted FDA Approval for Resonate ICD and CRT-D Systems

May 9, 2017 6:42 AM EDT Send to a Friend
Boston Scientific (NYSE: BSX) received FDA approval for the Resonateā„¢ family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login